Why we need a standard MRI protocol for multiple sclerosis across the UK
Professor Klaus Schmierer discusses the need for a standardized MRI protocol to ensure consistent, equitable access to care for people with MS across the UK.
Professor Klaus Schmierer is a member of the MAGNIFY-MS steering committee and MSGAN (Merck). He receives: speaking honoraria from, and/or served in an advisory role for, Biogen, Merck, Novartis, Roche, Teva; remuneration for teaching activities from EXCEMED & MS Academy; and is supported for attendance of meetings by Merck, Novartis, Roche. He receives research support from Barts Charity, Lipomed, Merck, Morris-Saady Charitable Trust, National Institute for Health Research, MS Society of Great Britain & Northern Ireland and National MS Society (US).